Dr. Scott Pomeroy, MD

• Pediatric Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Washington University, Child Neurology And Neurobiology

  Fellowship Hospital, 1990

• Washington University Children's Hospital, Child Neurology

  Residency Hospital, 1987

• Boston Children's Hispital, Pediatrics

  Residency Hospital, 1984

• Boston Children's Hispital, Pediatrics|washington University Children's Hospital, Child Neurology

  Residency Hospital, 1984

• University Of Cincinnati College Of Medicine

  Medical School, 1982

• English

• Spanish

• DiSCoVERing innovative therapies for rare tumors: combining genetically accurate disease models within silicoanalysis to identify novel therapeutic targets, 2016-03-24

• Medulloblastoma biology in the post-genomic era, 2013-03-11

• Frequent amplification of a chr19q13.41 microRNA polycistron (C19MC) in aggressive primitive neuro-ectodermal brain tumors, 2009-12-08

• SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation, 2016-12-12

• CNS-PNETs withC19MCamplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity, 2014-05-20

• Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma, 2012-03-10

• MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS, 2012-08-02

• The G-protein Alpha Subunit Gsa Is A Tumor Suppressor In Sonic Hedgehog-driven Medulloblastoma, 2014-08-24

• Rapid discrimination of pediatric brain tumors by mass spectrometry imaging, 2018-08-20

• Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenicPTENvariants across three centers, 2022-03-23

• Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis, 2013-10-17

• Integrative genomic analyses identify LIN28 and OLIG2 as markers of survival and metastatic potential in childhood central nervous system primitive neuro-ectodermal brain tumours, 2013-01-08

• Activation of ß-catenin/TCF targets following loss of the tumor suppressor SNF5, 2013-02-25

• Risk stratification of childhood medulloblastoma in the molecular era: The Current Consensus, 2016-04-04

• The whole-genome landscape of medulloblastoma subtypes, 2017-07-20

• Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8, 2006-09-12

• TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma, 2021-02-08

• Intellectual and Developmental Disabilities Research Centers: Fifty Years of Scientific Accomplishments, 2019-07-27

• Resolving medulloblastoma cellular architecture by single-cell genomics, 2019-07-24

• Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group, 2013-11-22

• ICGC PedBrain: Dissecting the genomic complexity underlying medulloblastoma, 2012-08-02

• TERTpromoter mutations are highly recurrent in SHH subgroup medulloblastoma, 2013-10-31

• ICGC PedBrain - dissecting the genomic complexity underlying medulloblastoma using whole-genome sequencing, 2012-10-01

• Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups, 2018-09-10

• OTX2 activity at distal regulatory elements shapes the chromatin landscape of Group 3 medulloblastoma, 2017-02-17

• Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition, 2014-03-17

• Pineoblastoma segregates into molecular sub-groups with distinct clinicopathologic features: A Rare Brain Tumor Consortium registry study, 2019-12-09

• a5-GABAA receptors negatively regulateMYC-amplified medulloblastoma growth, 2013-11-07

• Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences, 2011-02-08

• The whole-genome landscape of medulloblastoma subtypes, 2017-07-19

• Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway, 2010-11-14

• HumanTUBB3mutations perturb microtubule dynamics, kinesin interactions, and axon guidance, 2010-01-08

• Firstin vivotesting of compounds targeting Group 3 medulloblastomas using an implantable microdevice as a new paradigm for drug development, 2017-01-25

• Medulloblastomics: The End of the Beginning, 2013-05-23

• Subgroup specific structural variation across 1,000 medulloblastoma genomes, 2012-08-02

• WNT activation by lithium abrogatesTP53mutation associated radiation resistance in medulloblastoma, 2014-12-24

• Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas, 2012-02-23

• Recurrent somatic alterations ofFGFR1andNTRK2in pilocytic astrocytoma, 2013-06-30

• The landscape of somatic copy-number alteration across human cancers, 2010-02-18

• Epigenetic antagonism between Polycomb and SWI/SNF complexes during oncogenic transformation, 2010-10-19